Khoo S - Search Results

1

Stockdale AJ, Khoo S. Stockdale AJ, et al. Among authors: khoo s. Curr Opin HIV AIDS. 2022 Jan 1;17(1):4-14. doi: 10.1097/COH.0000000000000709. Curr Opin HIV AIDS. 2022. PMID: 34740228 Review.

2

Differences in the pharmacokinetics of protease inhibitors between healthy volunteers and HIV-infected persons.

Dickinson L, Khoo S, Back D. Dickinson L, et al. Among authors: khoo s. Curr Opin HIV AIDS. 2008 May;3(3):296-305. doi: 10.1097/COH.0b013e3282f82bf1. Curr Opin HIV AIDS. 2008. PMID: 19372982

3

Clinical application of the inhibitory quotient: is there a role in HIV protease inhibitor therapy?

Winston A, Khoo S. Winston A, et al. Among authors: khoo s. Curr Opin HIV AIDS. 2008 Nov;3(6):608-11. doi: 10.1097/COH.0b013e328312972e. Curr Opin HIV AIDS. 2008. PMID: 19373031

4

British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012.

Williams I, Churchill D, Anderson J, Boffito M, Bower M, Cairns G, Cwynarski K, Edwards S, Fidler S, Fisher M, Freedman A, Geretti AM, Gilleece Y, Horne R, Johnson M, Khoo S, Leen C, Marshall N, Nelson M, Orkin C, Paton N, Phillips A, Post F, Pozniak A, Sabin C, Trevelion R, Ustianowski A, Walsh J, Waters L, Wilkins E, Winston A, Youle M. Williams I, et al. Among authors: khoo s. HIV Med. 2012 Sep;13 Suppl 2:1-85. doi: 10.1111/j.1468-1293.2012.01029.x. HIV Med. 2012. PMID: 22830364 Free article.

5

Key drug-drug interactions with direct-acting antiviral in HIV-HCV coinfection.

El-Sherif O, Khoo S, Solas C. El-Sherif O, et al. Among authors: khoo s. Curr Opin HIV AIDS. 2015 Sep;10(5):348-54. doi: 10.1097/COH.0000000000000185. Curr Opin HIV AIDS. 2015. PMID: 26248122 Review.

6

Pharmacokinetics and Safety of Darunavir/Ritonavir in HIV-Infected Pregnant Women.

Khoo S, Peytavin G, Burger D, Hill A, Brown K, Moecklinghoff C, La Porte C, Hadacek MB. Khoo S, et al. AIDS Rev. 2017 Jan-Mar;19(1):16-23. AIDS Rev. 2017. PMID: 28182610 Review.

7

Drug interactions and the role of pharmacokinetic trials in guiding choices in first-line HIV therapy in low-income and middle-income countries.

Seden K, Boffito M, Khoo S. Seden K, et al. Among authors: khoo s. Curr Opin HIV AIDS. 2017 Jul;12(4):377-382. doi: 10.1097/COH.0000000000000384. Curr Opin HIV AIDS. 2017. PMID: 28570369 Review.

8

Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naïve HIV-1-infected individuals.

Jackson A, Else L, Higgs C, Karolia Z, Khoo S, Back D, Devitt E, Pozniak A, Boffito M. Jackson A, et al. Among authors: khoo s. HIV Clin Trials. 2018 Feb;19(1):31-37. doi: 10.1080/15284336.2017.1408928. Epub 2017 Nov 30. HIV Clin Trials. 2018. PMID: 29189101

9

Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individuals.

Mora-Peris B, Bouliotis G, Ranjababu K, Clarke A, Post FA, Nelson M, Burgess L, Tiraboschi J, Khoo S, Taylor S, Ashby D, Winston A. Mora-Peris B, et al. Among authors: khoo s. AIDS. 2018 May 15;32(8):1007-1015. doi: 10.1097/QAD.0000000000001786. AIDS. 2018. PMID: 29438199 Free article. Clinical Trial.

10

Clinical Pharmacodynamics, Pharmacokinetics, and Drug Interaction Profile of Doravirine.

Boyle A, Moss CE, Marzolini C, Khoo S. Boyle A, et al. Among authors: khoo s. Clin Pharmacokinet. 2019 Dec;58(12):1553-1565. doi: 10.1007/s40262-019-00806-9. Clin Pharmacokinet. 2019. PMID: 31388941 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,155 results

Search Page